Pharmaceutical

Resolution scores $83m to develop macrophage cell therapies

Resolution plans to use Series B investment to advance the development of its macrophage therapies in inflammatory and fibrotic indications.

Oct 4, 2024 - 04:00
Resolution scores $83m to develop macrophage cell therapies
Resolution plans to use Series B investment to advance the development of its macrophage therapies in inflammatory and fibrotic indications.
Read the original article

Tags:

Previous Article

A rational design approach to RNA-targeting to target large-scale screening

Next Article

Chronic diseases “as urgent as climate change,” says Novo Nordisk CSO

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

STAT+: An exit interview with Bristol Myers Squibb CEO ...

Oct 30, 2023

Republicans say they’ll stop fentanyl at the border. But what are their plans for treatment?

Republicans say they’ll stop fentanyl at the border. Bu...

Sep 6, 2023

Organization behind ProMed defends move to subscription-based model

Organization behind ProMed defends move to subscription...

Aug 5, 2023